NAFDAC says there is no cure for COVID-19 yet and any claim of cure must be subjected to clinical trials following an approved clinical trial protocol.
Speaking during an online news conference on Tuesday, the Director-General, NAFDAC, Mojisola Adeyeye, said the 40 herbal formulations were currently undergoing review to ensure their safety for use.“In March 2019, we inaugurated the Nigerian Herbal Medicine Product Committee to bridge the gap often created between traditional medicine practitioners and researchers.
“COVID-19 pandemic created an opportunity and we have been encouraging traditional medicine practitioners to submit their herbal formulations for evaluation. “We also developed guidelines on how to register herbal medicine online and the labelling of the product. “Prof. Maurice Iwu’s application for approval of a herbal medicine for management of COVID-19, is also part of the 40 applications we are reviewing for safety.Mrs Adeyeye noted that there is no cure for COVID-19 yet and warned that any claim of cure must be subjected to clinical trials following an approved clinical trial protocol.
“Until a clinical trial is done in a scientific manner, no herbal medicine manufacturer can claim cure or effectiveness to treat COVID-19 associated symptoms.“They have a lot of potential and it is time to translate research of herbs into products of proven safety and efficacy, for the benefit of our people,” Mrs Adeyeye said.
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19: 40 Herbal Medicines Currently Undergoing Review – NAFDAC DGThe National Agency for Foods and Drugs Administration and Control (NAFDAC), on Tuesday said it received about 40 applications for the approval of herbal formulations\u00a0for the treatment of COVID-19 from researchers in the country. Speaking during an online news conference, Prof. Mojisola Adeyeye, Director-General, NAFDAC, said that the 40 herbal formulations were currently undergoing review
Read more »
Chloroquine kills COVID-19 virus in early stages – NAFDACThe Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye...
Read more »
Chloroquine potent for COVID-19 prevention — NAFDACWe are a quality, national, newspaper with credible and dependable information.
Read more »
COVID-19: Chloroquine Kills Virus In Early Stages – NAFDACThe National Agency for Food and Drug Administration and Control (NAFDAC), has revealed that reliable researches show that chloroquine can kill COVID-19 virus at the early stage. Director-general of NAFDAC, Prof. Moji Adeyeye, who disclosed this at a virtual press conference\u00a0yesterday in Abuja, also said that remdesivir, a product of\u00a0 Gilead Sciences Inc, has been
Read more »